Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CK Regeon

Request full access

Wnt/β-catenin pathway drugs for regenerative medicine applications

South KoreaFounded 2017

About CK Regeon

CK Regeon Inc. is a South Korean biotechnology firm established in October 2016 by Professor Kang-Yell Choi of Yonsei University. The company spun out from the Transnational Research Center for Protein Function Control (TRCP), a government-funded drug development institute that Dr. Choi had directed for over a decade. Dr. Choi, who holds a Ph.D. in biochemistry from Purdue University and conducted postdoctoral research at Harvard Medical School, founded CK Regeon to commercialize his extensive research on cellular signaling pathways, particularly the Wnt/β-catenin pathway.

The company's core focus is the development of First-in-Class, small-molecule drugs that address unmet medical needs by targeting the Wnt/β-catenin signaling pathway, which is crucial for tissue regeneration. A key discovery underpinning their technology is the role of the CXXC-type zinc finger protein 5 (CXXC5). CK Regeon identified that CXXC5 acts as a negative feedback regulator that suppresses the Wnt/β-catenin pathway by binding to the Dishevelled (Dvl) protein, and that this protein is overexpressed in damaged or diseased tissues. By developing drugs that inhibit this CXXC5-Dvl interaction, the company aims to restore the natural regenerative capabilities of tissues.

CK Regeon's therapeutic pipeline targets a range of conditions characterized by suppressed Wnt signaling. One of its leading drug candidates is KY19382, an oral small molecule that dually inhibits both the CXXC5-Dvl interaction and GSK3β to activate the Wnt pathway. This candidate has shown potential in preclinical studies for treating metabolic diseases like obesity and non-alcoholic steatohepatitis (NASH), demonstrating significant weight loss in high-fat diet animal models. The company is also developing topical applications of its technology to promote hair regrowth and accelerate wound healing. The compound KY19382 has demonstrated the ability to induce hair follicle neogenesis (the formation of new hair follicles) and accelerate cutaneous wound closure in animal studies. In July 2025, the company announced the launch of a cosmetic line under the brand names 'Herabone' and 'Hair Region', which includes shampoos and microneedle products for scalp health, marking a step towards commercialization.

Source: Dealroom company data

At a glance

Status
Operational
Employees
10
Open positions
None listed
Dealroom signal
31.9/100

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Feb 2021 $11M $45M Synergy IB Investment ↗
SERIES A✓Equity / VC Jan 2018 $5M $20M Undisclosed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

CK Regeon website traffic

Latest recorded traffic for CK Regeon is 2.1K monthly website visits, down 71.6% over the last three months. CK Regeon's team declined 16.7% over the past year.

Latest monthly visits2.1K 3-month web change-71.6% 1-year team growth-16.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

CK Regeon in its local ecosystem

Live from Dealroom

The CK Regeon office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Synergy IB Investment
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇰🇷 South Korea100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CK Regeon on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CK Regeon’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.